Yelensky Roman's Form 4/A amendment
AmendedGritstone bio, Inc. (GRTS) · filed Nov 19, 2021
- Accession no.
- 0001567619-21-020893
- Filed
- Nov 19, 2021
- Trade date
- Jan 19, 2021
- Filing delay
- 304 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 21, 2021
This filing lists 1 non-derivative transaction. Open-market sales total $221.0K. It was filed 304 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yelensky RomanCIK 0001754293 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2021 | Common Stock | SSaleDisposed | −10,000 | $22.10F1 | −$221,000 | 160,624 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $22.00 to $22.40 per share. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
Includes 27,400 RSUs which are subject to vesting.
Remarks
Executive Vice President and Chief Technology Officer